Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2567801 | Pulmonary Pharmacology & Therapeutics | 2008 | 12 Pages |
Abstract
Ciclesonide 320 μg and FP 330 μg administered twice daily over 6 months provided similar efficacy in patients with moderate or severe persistent asthma previously well-controlled by high doses of ICS at baseline. Ciclesonide was associated with fewer local AEs than FP.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
E.D. Bateman, A.E. Linnhof, L. Homik, U. Freudensprung, L. Smau, R. Engelstätter,